J. Sagar Associates (JSA) advised Monarch Networth Capital Limited and HDFC Bank Limited in relation to the qualified institutions placement of Alembic Pharmaceuticals Limited (“Alembic”). Alembic had filed a placement document on August 6, 2020 for issue of 80,47,210 equity shares to qualified institutional buyers aggregating INR 749.99 crore.
Alembic is a vertically integrated pharmaceutical company, developing, manufacturing and marketing of formulations offered in the international markets including in markets such as the United States, European Union, etc, formulations which cater to India’s domestic formulations market and active pharmaceutical ingredients which cater to both domestic and international markets.
JSA Team comprised Partner – Arka Mookerjee; Independent Senior Consultant – Madhurima Mukherjee; Principal Associate – Pracheta Bhattacharya; and Associates – Krupa Brahmbhatt, Sourav Modi and Kairav Parikh.
Arka’s practice area covers primarily equity capital markets issuances which covers a wide range of products such as Initial Public Offerings, Rights Issues, Qualified Institutions Placements, Initial Public Offering of Infrastructure Trusts and foreign currency convertible bonds.